Facilities
Paragon’s facilities are designed and built specifically for small-batch production of proteins monoclonal antibodies, recombinant vaccines, and Virus-like particles (VLPs) at smaller scales and under cGMP regulations, suitable for Phase I/II clinical trials, diagnostics or research purposes.
Segregated suites for mammalian, baculovirus or microbial production and purification.
- Upstream suites are classified as ISO 8 with single pass, positive pressure class 100,000 HEPA filtered air.
- Downstream suites are classified as ISO 7 with single pass, positive pressure class 10,000 HEPA filtered air
Prevention of cross-contamination:
- Unidirectional flow of personnel and materials
- Entry and exit airlocks
- Single-use disposables
- The suites are monitored by a 24/7 security system and HVAC monitoring system.
- Environmental monitoring program ensures the suites are cleaned and maintained to cGMP specifications.
Contact us for additional information or to request a proposal.